Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
GenFleet Therapeutics to Present Data from Phase I Trial of GFH009 Monotherapy at the 2022 Annual Meeting of American Society of Hematology (ASH)
2022-11-28 19:00
Chemotherapy may be completed within 8 days with two doses of Polytaxel, an innovative anticancer drug from South Korea's biotech firm
2022-11-25 21:00
Mabwell Announces the U.S. FDA approval of 9MW3011 (FIC) for IND
2022-11-24 21:00
Jiangsu Traditional Chinese Medicine International Exchange Conference kicked off in Nanjing
2022-11-23 14:19
Illuccix® Available on High Activity Gallium Generator Technology to Meet High Demand
2022-11-22 20:00
IND approval from the US FDA for theranostic SAR-Bombesin trial in prostate cancer
2022-11-21 22:04
Ainos Publishes Preclinical Data Demonstrating its VELDONA Formulation's Potential as Treatment Candidates for the Most Common Medical Conditions for Companion Animals
2022-11-21 18:30
Nona Biosciences Enters into HCAb Based Drug Discovery Collaboration Agreement with Dragonfly Therapeutics
2022-11-21 17:31
Lianhua Respiratory Health Products to Assure the Smooth Holding of Hainan International Health Industry Expo
2022-11-21 16:42
MEDICOX Signs Contract with ORAMED to Distribute Oral Insulin in South Korea
2022-11-18 17:11
Standigm Synthetic Research Center successfully accelerates drug discovery in its first year
2022-11-17 08:45
Simcere and Idorsia enter into a licensing agreement for daridorexant in China
2022-11-16 08:32
HanAll Biopharma Reports Third Quarter 2022 Results and Provides Business Update
2022-11-15 20:00
Daewoong Pharmaceutical Surpasses KRW 300 Billion in Q3 Revenue as Nabota Sales Grew by 93%, Leading Overall Growth in Revenue
2022-11-15 20:00
Nona Biosciences Announces Attendance at PEGS Europe 2022
2022-11-15 15:57
HARBOUR BIOMED LAUNCHES NONA BIOSCIENCES' "IDEAS TO IND" PRECLINICAL SOLUTIONS BUSINESS TO ACCELERATE GLOBAL BIOTHERAPEUTIC INNOVATION
2022-11-15 12:19
Nuance Pharma Announces Clearance of IND Application for Respiratory Syncytial Virus (RSV) Vaccine in China
2022-11-14 09:54
SK Biopharmaceuticals Receives Korea Drug Development Fund Investment Grant to Develop Novel Oncology Candidate, SKL27969
2022-11-14 08:00
Antengene Presents Promising Results from Four Preclinical Studies at the 2022 Society for Immunotherapy of Cancer Annual Meeting
2022-11-11 08:30
CBC-backed ABio-X appoints pharmaceutical and healthcare veteran Dr. Jeffrey Jonas as CEO
2022-11-10 21:00
1
63
64
65
66
67
165